Published in Can Med Assoc J on December 01, 1982
Enteroviruses in human disease. Prog Med Virol (1978) 3.18
A clinical, epidemiologic and laboratory investigation of aseptic meningitis during the four-year period, 1955-1958. II. The clinical disease and its sequelae. N Engl J Med (1962) 2.03
A clinical, epidemiologic and laboratory investigation of aseptic meningitis during the four-year period, 1955-1958. I. Observations concerning etiology and epidemiology. N Engl J Med (1962) 1.79
Fatal echovirus 11 infections in outbreak in special-care baby unit. Lancet (1978) 1.39
Sequelae of central-nervous-system enterovirus infections. N Engl J Med (1975) 1.33
Poliomyelitis in hypogammaglobulinemics. J Infect Dis (1973) 1.27
Meningitis after lumbar puncture in children with bacteremia. N Engl J Med (1981) 1.24
Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med (1977) 1.20
Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J Pediatr (1980) 1.13
An epidemic of aseptic meningitis due to echo-virus type 30: epidemiologic features and clinical and laboratory findings. Am J Public Health Nations Health (1970) 1.11
Fatal echovirus 11 disease in premature neonates. Pediatrics (1980) 1.10
The importance of lactic acid levels in body fluids in the detection of bacterial infections. Rev Infect Dis (1981) 0.99
Human diploid cell cutures in diagnosis of echovirus 30 meningitis. Arch Intern Med (1970) 0.97
Echovirus type 30 meningitis and related febrile illness: epidemiologic study of an outbreak in an Eskimo community. Am J Epidemiol (1970) 0.94
Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. J Pediatr (1977) 0.93
Coxsackievirus B5 infection and aseptic meningitis in neonates and children. Am J Dis Child (1975) 0.92
"Mixed" meningitis. Report of a case with isolation of Haemophilus influenzae type B and ECHO virus type 9 from the cerebrospinal fluid. N Engl J Med (1962) 0.92
Longitudinal assessment of children with enteroviral meningitis during the first three months of life. Pediatrics (1981) 0.91
Evaluation of cerebrospinal fluid lactic acid levels as an aid in differential diagnosis of bacterial and viral meningitis in adults. J Clin Microbiol (1980) 0.87
Simultaneous infection of the meninges by Coxsackie B virus and Neisseria meningitidis in an elderly female. Lancet (1976) 0.87
Aseptic meningitis epidemic involving ECHO 4 and Coxsackie B5 viruses. Public Health Rep (1970) 0.86
Simultaneous bacterial and viral infections of meninges. Lancet (1977) 0.86
ISOLATION OF HERPESVIRUS HOMINUM FROM THE CEREBROSPINAL FLUID OF A CHILD WITH BACTERIAL MENINGITIS AND GINGIVOSTOMATITIS. J Pediatr (1964) 0.86
An outbreak caused by coxsackievirus B5 among newborn infants. Scand J Infect Dis (1972) 0.85
Is the CSF lactate measurement useful in the management of children with suspected bacterial meningitis? J Pediatr (1981) 0.85
Value of second lumbar puncture in confirming a diagnosis of aseptic meningitis. A prospective study. Arch Neurol (1979) 0.84
An epidemic of aseptic meningitis, primarily among infants, caused by echovirus 11-prime. Pediatrics (1968) 0.83
A comparative study of meningoencephalitis epidemics caused by echovirus type 7 and coxsackievirus type B5. Clinical and virological observations during two epidemics in northern Sweden. Scand J Infect Dis (1975) 0.82
A winter outbreak of ECHO virus type 9 meningitis in Jerusalem, with cases of a simultaneous mixed pneumococcal-viral infection. Isr J Med Sci (1971) 0.82
An epidemic of aseptic meningitis syndrome due to ECHO virus type 6. III. Sequelae three years after infection. Pediatrics (1962) 0.82
Meningococcal and ECHO-9 meningitis. Report of an outbreak. Neurology (1970) 0.81
A follow-up study of 15 cases of neonatal meningoencephalitis due to Coxsackie virus B5. J Pediatr (1975) 0.81
Echovirus-11 infection in a special-care baby unit. Lancet (1979) 0.79
Aseptic meningitis due to echovirus type 9. Can J Public Health (1972) 0.77
Echovirus type 4 meningitis and related febrile illness: epidemiologic study of an outbreak in two Eskimo communities in 1970. Am J Epidemiol (1972) 0.77
Echovirus type 4 infections in Scotland, 1971-72. Scand J Infect Dis (1975) 0.77
An epidemic of echovirus type 30 meningitis in an arctic community. Am J Epidemiol (1974) 0.77
Viral aseptic meningitis: 12 years' experience. Mo Med (1971) 0.77
Characteristics of an Echovirus type 30 strain isolated during an epidemic of aseptic meningitis in New York in 1968. Am J Epidemiol (1971) 0.77
A community and intensive care nursery outbreak of coxsackievirus B5 meningitis. Am J Dis Child (1974) 0.77
Echoviruses types 4 and 9 in an outbreak of aseptic meningitis in Jerusalem. Scand J Infect Dis (1970) 0.77
Countercurrent immunoelectrophoresis in the diagnosis of viral infections of the central nervous system. J Infect Dis (1978) 0.77
Follow-up study of 18 infants with history of Coxsackie B-5 virus meningitis during neonatal period. Acta Paediatr Scand (1967) 0.76
An outbreak of aseptic meningitis in the area of Fort Smith, Arkansas, 1975, due to echovirus type 4. J Ark Med Soc (1977) 0.76
Enteroviral meningitis: A reappraisal. Pediatrics (1978) 0.76
[Meningitis aused by ECHO-30 virus in children]. Presse Med (1971) 0.76
[Epidemic due to echo virus 30. I. Clinical and biological study]. Ann Pediatr (Paris) (1970) 0.76
Aseptic meningitis associated with echovirus type 9' on Oahu, Hawaii. Am J Public Health Nations Health (1970) 0.76
The long-term prognosis of aseptic meningitis in childhood. Dev Med Child Neurol (1970) 0.76
Aseptic meningitis associated with ECHO virus, type 9: an outbreak in Norfolk, Virginia. South Med J (1970) 0.76
[Letter: Meningitis epidemic due to Echo 30 (1974) virus]. Nouv Presse Med (1974) 0.76
Evaluation of the effectiveness of immunization delivery methods. Can J Public Health (1995) 2.36
Evaluation of rubella screening in pregnant women. CMAJ (1998) 1.81
Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J Acquir Immune Defic Syndr (1992) 1.78
Evaluation of donor skin disinfection methods. Transfusion (1997) 1.71
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
Health spa whirlpools: a source of Pseudomonas folliculitis. Can Med Assoc J (1981) 1.63
Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr (1992) 1.56
Rotavirus vaccine withdrawal in the United states; the role of postmarketing surveillance. Can J Infect Dis (2000) 1.47
Infectious diseases as a subspecialty in Canada: status of the practice in Quebec. Rev Infect Dis (1991) 1.39
Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT). Clin Infect Dis (1999) 1.26
The risks and benefits of accepting men who have had sex with men as blood donors. Transfusion (2003) 1.21
Bacterial contamination in platelet concentrates. Vox Sang (2014) 1.18
Risk of HIV infection from blood transfusion in Montreal. CMAJ (1997) 1.16
Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion (2001) 1.16
Acquired (or congenital) immunodeficiency syndrome in infants born of Haitian mothers. N Engl J Med (1983) 1.15
Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol (1996) 1.14
Hemophilus influenzae type b infections: recurrent disease due to ampicillin-resistant strains. J Pediatr (1977) 1.12
Severe protracted diarrhea due to multiresistant adherent Escherichia coli. Am J Dis Child (1984) 1.10
Prevalence of hepatitis B virus infection in pregnant women in the Montreal area. CMAJ (1986) 1.06
Giant-cell pneumonia caused by parainfluenza virus. J Pediatr (1979) 1.04
Biological and clinicopathological features associated with hepatitis C virus type 5 infections. J Hepatol (1996) 1.04
Immunization delivery methods: practice recommendations. Can J Public Health (1995) 1.03
Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol (2001) 1.00
Severe disseminated lung disease and bronchiectasis probably due to Mycoplasma pneumoniae. Can Med Assoc J (1977) 0.99
Bacteremia caused by viridans streptococci in 71 children. Can Med Assoc J (1981) 0.99
Adjuvant treatment with polyadenylic-polyuridylic acid (Polya.Polyu) in operable breast cancer. Lancet (1980) 0.98
Canadian Paediatric Surveillance Program evaluation: An excellent report card. Paediatr Child Health (2004) 0.98
Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children. Vaccine (2000) 0.97
Use of the 5' noncoding region for genotyping hepatitis C virus. J Infect Dis (1994) 0.95
Allowing blood donation from men who had sex with men more than 5 years ago: a model to evaluate the impact on transfusion safety in Canada. Vox Sang (2014) 0.95
Incidence of positive bacterial cultures after donor call-back. Transfusion (1996) 0.94
Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann. Am J Reprod Immunol (1997) 0.92
Should children with isolated anti-HBs or anti-HBc be immunized against hepatitis B virus? JAMA (1997) 0.92
Screening for HBsAg in pregnant women: a cost analysis of the universal screening policy in the province of Quebec. Can J Public Health (1991) 0.91
Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome. Arch Pathol Lab Med (1984) 0.90
Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory. Diagn Microbiol Infect Dis (2000) 0.89
The fecal microflora and bile acids in children with cystic fibrosis. Am J Clin Nutr (1979) 0.87
"Muskrat fever": two outbreaks of tularemia near Montreal. Can Med Assoc J (1982) 0.86
Hepatitis B Infection in Canada: Epidemiology and implications for control. Can Fam Physician (1992) 0.86
Occult hepatitis B infection in blood donors. Vox Sang (2008) 0.86
Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial. Br Med J (Clin Res Ed) (1984) 0.85
A fatal case of transfusion-transmitted Staphylococcus epidermidis sepsis. Transfusion (2001) 0.85
Tuberculous meningitis in children: a retrospective study of 79 patients, with an analysis of prognostic factors. Can Med Assoc J (1979) 0.85
Set-up and routine use of a database of 10,555 genotyped blood donors to facilitate the screening of compatible blood components for alloimmunized patients. Vox Sang (2009) 0.83
Serogroups and serotypes of pneumococci in Montreal: correlations with age, outcome and indications for vaccination. Can Med Assoc J (1984) 0.83
Immuno-endocrine interactions in early pregnancy. Hum Reprod (1995) 0.82
A monoclonal antibody to the double-stranded polyribonucleotide complex poly(A) X poly(U). Mol Immunol (1984) 0.82
Ontogeny of the humoral immune response to human immunodeficiency virus type 1 in infants. J Infect Dis (1993) 0.82
Pathogens in children with severe combined immune deficiency disease or AIDS. CMAJ (1986) 0.81
Inventory management. Vox Sang (2010) 0.81
Favus: twenty indigenous cases in the province of Quebec. Arch Dermatol (1978) 0.81
A murine model of NK cell mediated resorption. Am J Reprod Immunol (1990) 0.80
Transmission of HIV-1 from seronegative but PCR-positive blood donor. Lancet (1992) 0.78
[Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)]. Chirurgie (1980) 0.78
Hepatitis C virus genotypes in patients and blood donors--Quebec. Can Commun Dis Rep (1995) 0.78
Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care. Vox Sang (2014) 0.78
[Prevalence of Aeromonas spp. pediatric gastroenteritis]. CMAJ (1988) 0.78
Alloimmunization against well defined polymorphic major histocompatibility or class I MHC transfected L cells antigens can prevent poly IC induced fetal death in mice. Am J Reprod Immunol (1995) 0.77
Immune response to verotoxin 1 and 2 in children with Escherichia coli O157:H7 hemorrhagic colitis and classic hemolytic uremic syndrome. Can J Infect Dis (1995) 0.76
[Giardia lamblia infestation at child day care centers. Nutritional impact in infested children]. Arch Fr Pediatr (1990) 0.76
Allergic transfusion reactions from blood components donated by IgA-deficient donors with and without anti-IgA: a comparative retrospective study. Vox Sang (2010) 0.76
Primary cutaneous nocardiosis due to Nocardia caviae. CMAJ (1987) 0.76
The effects of leg crossing and applied tension on blood donor return. Vox Sang (2013) 0.76
The role of leukodepletion in the control of transfusion-transmitted disease. Transfus Med Rev (1995) 0.76
A clinical study of rotavirus gastroenteritis. J Pediatr (1978) 0.76
Yersinia enterocolitica infection in children: 4 years experience in the Montreal urban community. Contrib Microbiol Immunol (1979) 0.76
Erysipeloid in an infant. J Pediatr (1981) 0.76
Early detection of HIV in neonates. N Engl J Med (1993) 0.75
[Dermatophytes isolated at a pediatric hospital in Montreal from 1954 to 1979]. Can Med Assoc J (1982) 0.75
Mixed infections with Hemophilus influenzae type b. Can Med Assoc J (1979) 0.75
[Development of the risk of infection in the child with leukemia]. Can Med Assoc J (1983) 0.75
Primary Pseudomonas aeruginosa meningitis in a 2-year-old boy. Can Med Assoc J (1977) 0.75
[The possible relation between hepatitis B vaccination and chronic fatigue syndrome]. Union Med Can (1993) 0.75
[Pertussis. Retrospective study of cases at Sainte-Justine (1973-1978)]. Union Med Can (1979) 0.75
Peracute streptococcal pyomyositis: report of two cases and review of the literature. J Pediatr Orthop (1986) 0.75
[The risk of infection in leukemic children: a retrospective study of 294 cases]. Union Med Can (1984) 0.75
[Bacterial gastroenteritis. Clinical and microbiologic study of 512 cases]. Union Med Can (1982) 0.75
[Bacteremia in children under the age of 1]. Union Med Can (1982) 0.75
Prion reduction of red-blood-cells. Vox Sang (2012) 0.75
[Histiocytic cells of pulmonary alveoli: extracellular evolution of secretion, in vitro; biochemical comparison with the surfactant]. C R Acad Sci Hebd Seances Acad Sci D (1970) 0.75
Randomized trial with Poly A-Poly U as adjuvant therapy complementing surgery in patients with breast cancer: in vitro study of cellular immunity. Recent Results Cancer Res (1978) 0.75
Chloroquine-resistant Plasmodium falciparum malaria acquired in central Africa--Quebec. Can Dis Wkly Rep (1988) 0.75
[Vaccination as a means of prevention]. J Dent Que (1989) 0.75
Practice survey of immunization in Canada. Can J Public Health (1995) 0.75
Blood donation clusters in Québec, Canada (2003-2008): spatial variations according to sex and age. Vox Sang (2013) 0.75
Clinical and laboratory practices in investigation of suspected transfusion-transmitted bacterial infection: a survey of Canadian hospitals. Vox Sang (2009) 0.75
[Septicemia associated with urinary infection in infants. Apropos of 36 cases]. Arch Fr Pediatr (1984) 0.75
[Diminution of the percentage of mononucleated phagocytes in patients with breast cancer]. C R Acad Sci Hebd Seances Acad Sci D (1977) 0.75
[Measles: current status]. Union Med Can (1981) 0.75
[Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial]. Chirurgie (1984) 0.75
[Neurologic complications of bacterial meningitis, in the acute stage, in children. Clinical and neuroradiologic study]. Union Med Can (1982) 0.75
A new adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer. Recent Results Cancer Res (1982) 0.75
Reduced incidence of spontaneous mammary tumors in C3H/He mice after treatment with polyadenylate-polyuridylate. Science (1975) 0.75
[Trials of (poly A. poly U) adjuvant immunotherapy in breast cancer treatment]. Bull Cancer (1975) 0.75
Cefoperazone: a comparative in vitro Canadian study of 1743 pathogens, Canadian Infectious Disease Study Group. Can J Public Health (1984) 0.75
[Immunization of children: current status and future prospects]. Union Med Can (1979) 0.75
Antiviral activity of fusafungine. Rhinol Suppl (1988) 0.75
Donation by donors with an atypical pulse rate does not increase the risk of cardiac ischaemic events. Vox Sang (2012) 0.75
[Tumor necrosis factor and induced labor]. Contracept Fertil Sex (1997) 0.75